CinCor Pharma Competitors and Similar CompaniesClear all
CinCor Pharma's competitors and similar companies include Neopharmed Gentili and Immatics.
 CinCor Pharma CinCor Pharma is a clinical-stage biopharmaceutical company targeting cardiovascular, metabolic, and kidney diseases. |  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | ||
Founding Date | Founding Date 2018 | Founding Date 2018 | Founding Date N/A |
Type | Type Subsidiary | Type Private | Type Public |
Tags | |||
Locations | Locations Waltham, US HQ | Locations Milano, IT HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US |
Employees | Employees 5 | Employees 428 | Employees 29723% increase |
Financial | |||
Net income | Net income ($50.4m) (FY, 2021) | Net income N/A | Net income (€196.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 193m | Total funding raised N/A | Total funding raised $ 267.3m |
For sources of this data, please see the company profile
View Company Profiles
Neopharmed Gentili
HQ
Milano, IT
Employees
428
Neopharmed Gentili is a pharmaceutical company.
View companyImmatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company